LAB. CORP.OF AMER. DL-,10
LAB. CORP.OF AMER. DL-,10/ US50540R4092 /
LAB
22/05/2024 18:14:28
|
Chg.
-
|
Volume |
Bid- |
Demandez à- |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
188.00EUR
|
-
|
- Chiffrre d'affaires: - |
-Bid taille: - |
-Ask la taille: - |
15.02 Mrd.EUR |
- |
- |
Description de l'entreprise
Laboratory Corporation of America® Holdings, an S& P 500 company, is the world's leading healthcare diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people's health by delivering the combination of world-class diagnostics, drug development and knowledge services.
Conseil d'administration & Conseil de surveillance
PDG |
Adam Schechter |
Conseil d'administration |
Glenn Eisenberg, Amy Summy, Anita Graham, Brian Caveney, Jon DiVincenzo, Lance Berberian, Mark Schroeder , Megan Bailey, Sandra van der Vaart, J.D., Peter J. Wilkinson |
Conseil de surveillance |
Adam H. Schechter, Kerrii B. Anderson, Jean-Luc Bélingard, Jeffrey A. Davis, D. Gary Gilliland M.D., Ph.D., Kirsten Kliphouse, Garheng Kong M.D., Ph.D., Peter M. Neupert, Richelle P. Parham, Paul B. Rothman, M. D., Kathryn E. Wengel, R. Sanders Williams, M.D. |
Données de l'entreprise
Nom: |
Laboratory Corporation of America Holdings |
Adresse: |
531 South Spring Street,Burlington, North Carolina 27215, USA |
Téléphone: |
+1-336-229-1127 |
Fax: |
+1-336-436-1569 |
Courriel: |
-
|
Internet: |
https://www.labcorp.com/ |
Industrie: |
Healthcare |
Secteur: |
Medical Products |
Sous-secteur: |
Advanced Medical Devices |
Fin de l'exercice financier: |
31/12 |
Flotte libre: |
78.40% |
IPO date: |
- |
Relations avec les investisseurs
Nom: |
Chas Cook |
Téléphone IR: |
+1-336-436-5076 |
IR-Fax: |
336-436-1569 |
E-mail IR: |
investor@labcorp.com
|
Calendrier de l'entreprise
CW 24 | 12/06/2024
Dividend Payment
|